Whiting USA Trust II EV/EBIT
What is the EV/EBIT of Whiting USA Trust II?
The EV/EBIT of Whiting USA Trust II is 0.32
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Energy sector on OTC compared to Whiting USA Trust II
What does Whiting USA Trust II do?
Whiting USA Trust II holds a term net profits interest in the oil and gas producing properties located in the Permian Basin, Rocky Mountains, Gulf Coast, and Mid-Continent regions of the United States. Its oil and gas properties include interests in approximately 364.1 net producing oil and natural gas wells located in 42 predominately mature fields with established production profiles in 8 states. The company was founded in 2011 and is based in Houston, Texas. Whiting USA Trust II is a subsidiary of Whiting Petroleum Corporation.
Companies with ev/ebit similar to Whiting USA Trust II
- Oncternal Therapeutics has EV/EBIT of 0.28
- Sulliden Mining Capital has EV/EBIT of 0.29
- J4 Ventures has EV/EBIT of 0.29
- Sulliden Mining Capital has EV/EBIT of 0.30
- Bio-Path Inc has EV/EBIT of 0.31
- Freeline Therapeutics plc has EV/EBIT of 0.31
- Whiting USA Trust II has EV/EBIT of 0.32
- Valencia Capital has EV/EBIT of 0.33
- BlueCity has EV/EBIT of 0.33
- Aclaris Therapeutics Inc has EV/EBIT of 0.35
- Zafgen has EV/EBIT of 0.35
- Xenetic Biosciences Inc has EV/EBIT of 0.35
- Ocwen has EV/EBIT of 0.35